Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
REHOVOT, Israel, August 7, 2013 /PRNewswire/ --
Israeli biomed company AIT (Advanced Inhalation Therapies Ltd.), a leader in the development of nitric oxide therapeutics for the treatment of infectious respiratory diseases, announced today the appointment of Andrew R. Colin, M.D., to its scientific advisory board.
Hey, check out all the research scientist jobs. Post your resume today!
